JENKEM(SH:688356)2025-04-28 13:30Revenue Performance - The company reported a revenue of CNY 69,104,053.22 for the first quarter of 2025, representing a 6.66% increase compared to CNY 64,788,995.56 in the same period last year[4]. - Total revenue for Q1 2025 reached ¥69,104,053.22, an increase of 6.9% compared to ¥64,788,995.56 in Q1 2024[12]. - The company achieved product sales revenue of CNY 67,351,300, a 5.91% increase year-on-year, with domestic sales declining by 68.20% to CNY 7,704,600, while international sales surged by 51.52% to CNY 59,646,700[9]. - Revenue from technical services increased by 74.66% to CNY 1,570,200, with both domestic and international technical service revenues showing growth[9]. Profitability - Net profit attributable to shareholders decreased by 17.79% to CNY 11,880,461.89 from CNY 14,452,078.78 year-on-year[4]. - Net profit for Q1 2025 was ¥11,880,461.89, down 17.5% from ¥14,452,078.78 in Q1 2024[13]. - The company reported a basic earnings per share of ¥0.20 for Q1 2025, down from ¥0.24 in Q1 2024[13]. Operating Activities - The net cash flow from operating activities was negative at CNY -11,064,447.38, a significant decline of 126.28% compared to CNY 42,100,504.42 in the previous year[4]. - Cash flow from operating activities in Q1 2025 was ¥36,285,255.93, significantly lower than ¥108,269,854.28 in Q1 2024, a decline of 66.5%[15]. - Cash outflows related to operating activities totaled $47.35 million, a decrease from $66.17 million, indicating improved cost management[16]. Research and Development - Research and development (R&D) expenses totaled CNY 19,258,551.25, an increase of 19.96% from CNY 16,053,711.87, with R&D expenses accounting for 27.87% of revenue, up from 24.78%[5]. - The company is progressing well with its R&D projects, with CNY 10,807,800 in expense-based R&D and CNY 8,450,700 in capitalized R&D related to the JK1201I project[9]. - Research and development expenses decreased to ¥10,807,829.30 in Q1 2025 from ¥16,053,711.87 in Q1 2024, a reduction of 32.5%[12]. Assets and Liabilities - The company reported a total asset value of CNY 1,374,398,798.49, a slight increase of 0.52% from CNY 1,367,260,388.85 at the end of the previous year[5]. - Total assets as of March 31, 2025, were ¥1,374,398,798.49, a slight increase from ¥1,367,260,388.85 at the end of 2024[11]. - Total liabilities decreased to ¥95,845,000.27 as of March 31, 2025, from ¥100,509,398.52 at the end of 2024, a reduction of 4.6%[11]. Cash Flow and Investments - The net cash flow from operating activities was -$11.06 million, a significant decrease compared to $42.10 million in the previous period, indicating a decline in operational performance[16]. - Total cash inflow from investment activities was $213.85 million, down from $292.21 million, reflecting reduced investment returns[16]. - The net cash flow from investment activities was -$22.47 million, an improvement from -$28.42 million, suggesting better management of investment outflows[16]. - Cash flow from financing activities resulted in a net outflow of -$5.91 million, compared to -$8.63 million previously, indicating a reduction in financing costs[16]. - The total cash and cash equivalents at the end of the period decreased to $102.81 million from $116.26 million, showing a decline in liquidity[16]. Accounts Receivable and Cash Management - Accounts receivable increased to ¥80,605,667.25 as of March 31, 2025, compared to ¥46,125,092.31 at the end of 2024, reflecting a rise of 74.6%[10]. - Cash and cash equivalents decreased to ¥102,812,986.01 as of March 31, 2025, from ¥146,810,151.00 at the end of 2024, a decline of 30%[10]. - The company received $208.11 million from investment recoveries, down from $290.31 million, highlighting a decrease in cash inflows from divestitures[16]. Future Outlook - Direct exports to the United States accounted for 17.36% of total revenue, with expectations of a shift towards non-U.S. customers in 2025[9]. - The company plans to implement new accounting standards starting in 2025, which may affect future financial reporting[16].